Literature DB >> 25075160

The role of imaging in hypertensive heart disease.

Edward T D Hoey1, Vijayabhaskar Pakala1, Jun K Teoh2, Helen Simpson2.   

Abstract

Hypertensive heart disease (HHD) describes a spectrum of target organ response that includes left ventricular hypertrophy, systolic, and diastolic dysfunction. A variety of imaging techniques can be used to assess the various aspects of HHD. Echocardiography has for many years been the main imaging technique in the evaluation of HHD, but there is an increasing role for cardiovascular magnetic resonance (CMR) imaging due to its ability to provide an unrestricted field of view and noninvasive tissue characterization. This article reviews the current role of imaging for HHD with particular focus on echocardiography and CMR applications.

Entities:  

Keywords:  echocardiography; hypertension; magnetic resonance imaging

Year:  2014        PMID： 25075160      PMCID： PMC4082450          DOI： 10.1055/s-0034-1370885

Source DB:  PubMed          Journal:  Int J Angiol        ISSN： 1061-1711


  37 in total

1.  On variations in the cardiac hypertrophic response to pressure overload.

Authors:  J Ross
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

2.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

Authors:  W B Kannel; T Gordon; D Offutt
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

3.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

Review 4.  Velocity-encoded cine MR imaging in aortic coarctation: functional assessment of hemodynamic events.

Authors:  Jeffrey J Hom; Karen Ordovas; Gautham P Reddy
Journal:  Radiographics       Date:  2008 Mar-Apr       Impact factor: 5.333

5.  Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo.

Authors:  Antonella Moreo; Giuseppe Ambrosio; Benedetta De Chiara; Min Pu; Tam Tran; Francesco Mauri; Subha V Raman
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-03       Impact factor: 7.792

Review 6.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

Authors:  Daniel Pewsner; Peter Jüni; Matthias Egger; Markus Battaglia; Johan Sundström; Lucas M Bachmann
Journal:  BMJ       Date:  2007-08-28

7.  New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.

Authors:  Khaled Alfakih; Kevin Walters; Tim Jones; John Ridgway; Alistair S Hall; Mohan Sivananthan
Journal:  Hypertension       Date:  2004-06-28       Impact factor: 10.190

8.  Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study.

Authors:  Arumugam Narayanan; Gerard P Aurigemma; Marcello Chinali; Jeffrey C Hill; Theo E Meyer; Dennis A Tighe
Journal:  Circ Cardiovasc Imaging       Date:  2009-07-21       Impact factor: 7.792

9.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

Authors:  James C C Moon; Bhavesh Sachdev; Andrew G Elkington; William J McKenna; Atul Mehta; Dudley J Pennell; Philip J Leed; Perry M Elliott
Journal:  Eur Heart J       Date:  2003-12       Impact factor: 29.983

10.  Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.

Authors:  Alicia M Maceira; Sanjay K Prasad; Philip N Hawkins; Michael Roughton; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-11-25       Impact factor: 5.364
View more
  1 in total

Review 1.  The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease.

Authors:  Sophie Mavrogeni; Vasiliki Katsi; Vasiliki Vartela; Michel Noutsias; George Markousis-Mavrogenis; Genovefa Kolovou; Athanasios Manolis
Journal:  BMC Cardiovasc Disord       Date:  2017-05-23       Impact factor: 2.298
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.